The ongoing consolidation of the CRO industry continued today as Clinipace Worldwide announced it will absorb Paragon Biomedical's operations.
Clinipace Worldwide, a growing CRO with proprietary clinical trials software, has fueled the expansion of its business with a fresh $15 million Series C round. Morgan Stanley Expansion Capital led...
The fast-growing clinical research organization Clinipace Worldwide has fattened its reserves with a $15 million C round led by Morgan Stanley Expansion Capital. The Morrisville, NC-based research
Clinipace Worldwide has its sights set on a European expansion. The company, which specializes in integrating its proprietary eClinical software into its CRO services, has agreed to buy Zurich,